[1] Krausz Y, Bonne O, Marciano R, et al. Brain SPECT imaging of neuropsychiatric disorders. Eur J Radiol, 1996, 21(3):183-187.
[2] Bonne O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed patients:a methodological comparison of statistical parametric mapping and region of interest analyses. Psyehiatry Res, 2003, 122(1):49-57.
[3] Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-corticol function and negative mood:converging PET findings in depression and normal sadness. Am J Psychiatry, 1999, 156(5):675-682.
[4] Drevets WC. Neuroimaging studies of mood disorder. Biol Psychiatry, 2000.48(8):813-829.
[5] Smith D J, Cavanagh JT. Tile use of single photon emission computed tomography in depressive disorders. Nucl Med Commun, 2005, 26(3):197-203.
[6] Videbeeh P. PET measurements of brain glucose metabolism and hlood flow in major depressive disorder:a critical review. Acta Psychiat Scand, 2000, 101(1):11-20.
[7] Vangu MD, Esser JD, Boyd IH, et al. Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsy chopharmacol Biol Psychiatry, 2003, 27(1):15-19.
[8] Tutus A, Simsek A, Sofuoglu S,et al. Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders:comparison of unipolar vs. bipolar subtypes. Psychiatry. Res, 1998, 83(3):169-177.
[9] Davies J, Lloyd KR, Jones IK, et al. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. Am J Psychiatry, 2003, 160(2):374-376.
[10] Perieo CA. Skaf CR, Yamada A, et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression:a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett, 2005, 384(3):265-270.
[11] Benabarre A, Vieta E, Martin F, et al. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar Ⅰ patients. Psychiatry Res, 2004, 132(3):285-289.
[12] Kruger S, Alda M, Young UF, et al. Risk and resilience markers in bipolar disorder:brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry, 2006, 163(2):257-264.
[13] Fountoulakis KN, Iacovides A, Gerasimou G, et al. The relationship of regional cerebral hlood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28(3):537-546.
[14] Gonul AS, Kula M, Bilgin AG, et al. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro-psychopharmacol Biol Psychiatry, 2004, 28(6):1015-1021.
[15] Bonne O, Krausz Y, Gorfine M, et al. Cerebral hypopeffusion in medication resistant, depressed patients assessed by Tc-99m HMPAO SPECT. J Affect Disord. 1996, 41(3):163-171.
[16] Kimura M, Shimoda K, Mizumura S, et al. Regional cerebral blood flow in vascular depression assessed by 123I-IMP SPECT. J Nippon Med Sch, 2003, 70(4):321-326.
[17] Drevets WC, Bogers W, Raichle ME, Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of legional glucose metabolism. Eur Neuro psychopharmacol, 2002, 12(6):527-544.
[18] Malison RT, Price Lld, Berman R, el al. Reduced brain serotonin transporter availability in major depression as measured by[123I]-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry, 1995, 44(11):1090-1098.
[19] Willeit M. Praschak-Rieder N, Neumeister A, et al.[123I]-[beta]-CIT SPECT imaging shows rednced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry, 2000, 47(6):482-489.
[20] van Dyck CH, Malinson RT, Staley JK, et al. Central serotonin transporter availability measured with[123I] [beta]-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry, 2004, 161(3):523-531.
[21] Cowen PJ. Serotouin receptor subtypes:implications for psychopharmacology. Br J Psychiatry Suppl, 1991, (12):7-14.
[22] Klimke A, Larisch R, Janz A, et al. Dopamine D2 receptor binding before and after treatment of major depression measured by[123I] IBZM SPECT. PsychiatlT Res, 1999, 90(2):91-101.